← FDA Drug Approvals (Drugs@FDA)

LAMOTRIGINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2018-11-30

Drug application

FDA Application #

ANDA207497

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMOTRIGINE

Generic name

LAMOTRIGINE

Active ingredients

LAMOTRIGINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

AMNEAL PHARMS

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2018-11-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown